{"product_id":"continuing-education-company-30th-annual-hypertension-diabetes-dyslipidemia-conference-2026","title":"Continuing Education Company 30th Annual Hypertension, Diabetes, \u0026 Dyslipidemia Conference 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos + file sub vtt +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: physicians specializing in: family or general practice, internal medicine, endocrinology, geriatric medicine, lipidology, hypertension\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eProgram Objectives\u003c\/p\u003e\n\u003ch3\u003eAs a result of this educational activity, participants should be better able to:\u003c\/h3\u003e\n\u003cp\u003eFormulate an efficient and effective assessment and monitoring plan of a patient’s condition as it relates to hypertension, diabetes, and dyslipidemia.\u003c\/p\u003e\n\u003cp\u003eUtilize current guidelines in the diagnosis and management of diabetes, hypertension, and dyslipidemia.\u003c\/p\u003e\n\u003cp\u003eDevelop individualized interventions and treatment strategies for patients presenting with hypertension, diabetes, and\/or dyslipidemia that will translate into improved long-term outcomes.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis conference is designed for physicians, nurse practitioners, physician assistants, and other related health care professionals specializing in areas of geriatric medicine, endocrinology, lipidology and\/or hypertension along with those managing patients with hypertension, diabetes, and\/or hyperlipidemia.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eWEDNESDAY, June 3, 2026\u003c\/p\u003e\n\u003cp\u003eDay 1: Focus on Diabetes\u003c\/p\u003e\n\u003cp\u003eWelcome\u003c\/p\u003e\n\u003cp\u003eA. Mullins, CHCP \u0026amp; J. Basile, MD\u003c\/p\u003e\n\u003cp\u003eStandards of Care in Type 2 Diabetes in 2026\u003c\/p\u003e\n\u003cp\u003eC. Low Wang, MD\u003c\/p\u003e\n\u003cp\u003eDiabetes and Metabolic Associated Steatotic Liver Disease (MASLD)-Evaluation and Treatment\u003c\/p\u003e\n\u003cp\u003eC. Wysham, MD\u003c\/p\u003e\n\u003cp\u003eNavigating GLP-1RA and SGLT2i Use in Your Patients with Diabetes and Obesity\u003c\/p\u003e\n\u003cp\u003eC. Low Wang, MD\u003c\/p\u003e\n\u003cp\u003e10:15 am: BREAK\u003c\/p\u003e\n\u003cp\u003eWeight Management in Those with Diabesity or Atypical Forms of Diabetes in the Adult\u003c\/p\u003e\n\u003cp\u003eC. Wysham, MD\u003c\/p\u003e\n\u003cp\u003eQuestions for the Faculty\u003c\/p\u003e\n\u003cp\u003eC. Low Wang, MD \u0026amp; C. Wysham, MD\u003c\/p\u003e\n\u003cp\u003eCases from the Faculty\u003c\/p\u003e\n\u003cp\u003eC. Low Wang, MD \u0026amp; C. Wysham, MD\u003c\/p\u003e\n\u003cp\u003eTHURSDAY, June 4, 2026\u003c\/p\u003e\n\u003cp\u003eDay 2: Focus on Hypertension\u003c\/p\u003e\n\u003cp\u003eWelcome\u003c\/p\u003e\n\u003cp\u003eA. Mullins, CHCP\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD\u003c\/p\u003e\n\u003cp\u003eWhat’s New in Outpatient Hypertension: Clinical Pearls from the New 2025 HTN Guideline\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD\u003c\/p\u003e\n\u003cp\u003eMRA’s (Steroidal and Non-Steroidal) and Aldosterone Synthase Inhibitors in Hypertension and Renal Disease\u003c\/p\u003e\n\u003cp\u003eG. Hundemer, MD\u003c\/p\u003e\n\u003cp\u003eHypertension in Older Women; Illuminating a Bright Spot\u003c\/p\u003e\n\u003cp\u003eB. Egan, MD\u003c\/p\u003e\n\u003cp\u003e10:30 am: BREAK\u003c\/p\u003e\n\u003cp\u003eRethinking Primary Aldosteronism\u003c\/p\u003e\n\u003cp\u003eG. Hundemer, MD\u003c\/p\u003e\n\u003cp\u003eReframing Goal BP to Align Patients and Providers on the Target\u003c\/p\u003e\n\u003cp\u003eB. Egan, MD\u003c\/p\u003e\n\u003cp\u003eQuestions for the Faculty\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD, G. Hundemer, MD, \u0026amp; B. Egan, MD\u003c\/p\u003e\n\u003cp\u003e12:30 pm: LUNCH BREAK (Working Lunch)\u003c\/p\u003e\n\u003cp\u003eCases in Hypertension\u003c\/p\u003e\n\u003cp\u003eK. Bryant, MD and above faculty\u003c\/p\u003e\n\u003cp\u003eFRIDAY, June 5, 2026\u003c\/p\u003e\n\u003cp\u003eDay 3: Focus on Dyslipidemia\u003c\/p\u003e\n\u003cp\u003eWelcome\u003c\/p\u003e\n\u003cp\u003eA. Mullins, CHCP\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD\u003c\/p\u003e\n\u003cp\u003eWhat’s New in the ACC\/AHA Cholesterol Guidelines?\u003c\/p\u003e\n\u003cp\u003eM. Blaha, MD\u003c\/p\u003e\n\u003cp\u003eApplying the 2026 ACC\/AHA Cholesterol Guidelines in Practice\u003c\/p\u003e\n\u003cp\u003eR. Dudum, MD\u003c\/p\u003e\n\u003cp\u003eWhat’s on the HORIZON with Lp(a): Comparing the Nearly Completed Lp(a) Trials\u003c\/p\u003e\n\u003cp\u003eM. Blaha, MD\u003c\/p\u003e\n\u003cp\u003e10:15 am: BREAK\u003c\/p\u003e\n\u003cp\u003eMaking Sense of Non-Statin Lipid-Lowering Therapies: The When and Why to Use Them\u003c\/p\u003e\n\u003cp\u003eR. Dudum, MD\u003c\/p\u003e\n\u003cp\u003eQuestions for the Faculty\u003c\/p\u003e\n\u003cp\u003eM. Blaha, MD \u0026amp; R. Dudum, MD\u003c\/p\u003e\n\u003cp\u003eCases in Lipids\u003c\/p\u003e\n\u003cp\u003eM. Blaha, MD \u0026amp; R. Dudum, MD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405721129156,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Continuing-Education-Company-30th-Annual-Hypertension-Diabetes-Dyslipidemia-Conference-2026.jpg?v=1784215341","url":"https:\/\/medicalcoursespro.com\/products\/continuing-education-company-30th-annual-hypertension-diabetes-dyslipidemia-conference-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}